InvestSMART

Anatara Lifesciences Ltd (ASX: ANR) - Announcements

- Current share price for ANR : $0.009

ASX company news and announcements for Anatara Lifesciences Ltd (ANR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anatara Lifesciences Ltd (ANR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anatara Lifesciences Ltd (ANR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anatara Lifesciences Ltd (ANR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Initial Director's Interest Notice 4 Sep 2018 8:28AM $0.600 $0.009 fallen by 98.50%
$3 Final Director's Interest Notice 3 Sep 2018 10:02AM $0.605 $0.009 fallen by 98.51%
$3 Appendix 4E & Audited Financial Statements 31 Aug 2018 10:58AM $0.590 $0.009 fallen by 98.47%
$3 Non-Executive Chairman & Non-Executive Director appointments 29 Aug 2018 8:55AM $0.570 $0.009 fallen by 98.42%
$3 CSO departure to pursue Humanitarian Applications 28 Aug 2018 8:17AM $0.605 $0.009 fallen by 98.51%
$3 Change in substantial holding 17 Aug 2018 12:18PM $0.630 $0.009 fallen by 98.57%
$3 Appendix 4C - quarterly 30 Jul 2018 8:26AM $0.780 $0.009 fallen by 98.85%
$3 Investor Presentation and Strategy Update 18 Jul 2018 9:11AM $0.650 $0.009 fallen by 98.62%
$3 Shareholder Letter 18 Jul 2018 9:10AM $0.650 $0.009 fallen by 98.62%
$3 Change of Director's Interest Notice 25 Jun 2018 8:20AM $0.670 $0.009 fallen by 98.66%
$3 Change of Director's Interest Notice 29 May 2018 2:17PM $0.840 $0.009 fallen by 98.93%
$3 Final Director's Interest Notice 17 May 2018 8:57AM $1.160 $0.009 fallen by 99.22%
$3 Anatara CEO announces retirement 17 May 2018 8:30AM $1.160 $0.009 fallen by 99.22%
$3 Investor Presentation on Zoetis exclusive global license 16 May 2018 1:39PM $1.600 $0.009 fallen by 99.44%
$3 Change in substantial holding 16 May 2018 9:40AM $1.620 $0.009 fallen by 99.44%
$3 Exclusive Global License Agreement with Zoetis 15 May 2018 9:50AM $1.445 $0.009 fallen by 99.38%
$3 Trading Halt 14 May 2018 8:49AM $1.445 $0.009 fallen by 99.38%
$3 Appendix 4C - quarterly 19 Apr 2018 8:27AM $1.500 $0.009 fallen by 99.40%
$3 Half Yearly Report and Accounts 22 Feb 2018 8:17AM $1.680 $0.009 fallen by 99.46%
$3 FDA approves the Human Food Safety Dossier 5 Feb 2018 8:29AM $1.750 $0.009 fallen by 99.49%
$3 Appendix 4C - quarterly 29 Jan 2018 9:25AM $1.660 $0.009 fallen by 99.46%
$3 R&D Tax Incentive Received 18 Jan 2018 9:38AM $1.690 $0.009 fallen by 99.47%
$3 Appendix 3B 29 Nov 2017 6:18PM $1.750 $0.009 fallen by 99.49%
$3 Change in substantial holding 14 Nov 2017 8:38AM $1.500 $0.009 fallen by 99.40%
$3 Results of Meeting 13 Nov 2017 1:21PM $1.460 $0.009 fallen by 99.38%

401 - 425 of 534 results

Page 17 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.